Is ferrous sulfate appropriate for treating microcytic anemia?

Ferrous Sulfate for Microcytic Anemia

Yes, ferrous sulfate is appropriate and remains the first-line treatment for microcytic anemia due to iron deficiency, with a recommended dose of 50–100 mg elemental iron once daily (e.g., one 200 mg ferrous sulfate tablet providing 65 mg elemental iron). 1, 2

Initial Treatment Approach

Start with once-daily dosing on an empty stomach:

• Prescribe one 200 mg ferrous sulfate tablet daily (providing 65 mg elemental iron), taken at least 1 hour before or 2 hours after meals for optimal absorption 1, 2
• The 2024 American Gastroenterological Association and 2021 British Society of Gastroenterology both give strong recommendations for once-daily rather than multiple daily doses 2
• A single 60 mg dose of elemental iron raises hepcidin levels that remain elevated for up to 48 hours, blocking further iron absorption during this window 2

Key administration details:

• Co-administer with 80–500 mg vitamin C to enhance absorption 2
• Avoid tea or coffee within one hour of dosing, as polyphenols inhibit iron uptake 2
• If gastrointestinal intolerance occurs, the tablet may be taken with meals, accepting a modest reduction in absorption 2

Monitoring Response

Check hemoglobin at 2 weeks to predict treatment success:

• An increase of ≥1 g/dL (or ≥10 g/L) indicates effective response and predicts ultimate success with 90% sensitivity and 79% specificity 1, 2, 3
• If this rise is absent, strongly consider switching to intravenous iron rather than continuing ineffective oral therapy 1, 2
• Continue monitoring hemoglobin every 4 weeks until normalization 1, 2

Duration of Therapy

Continue treatment for 3 months after hemoglobin normalizes:

• Once hemoglobin reaches normal range, oral iron must be continued for an additional 2–3 months to replenish iron stores 1, 2
• Monitor complete blood count every 6 months initially after treatment completion to detect recurrence 2

Managing Gastrointestinal Intolerance

If standard once-daily dosing causes significant side effects:

• Switch to alternate-day dosing (one tablet every other day) rather than changing to a different iron salt 1, 2
• Alternate-day regimens reduce gastrointestinal adverse events (relative risk 0.56) while maintaining comparable final hemoglobin increments after the same cumulative dose 1, 3
• Hemoglobin rise may be slower initially with alternate-day dosing (0.69 g/dL at 2 weeks vs. 1.03–1.38 g/dL with daily dosing), but final outcomes are similar 3
• Overall gastrointestinal adverse events occur in 12–31% of patients, including constipation (12%), diarrhea (8%), and nausea (11%) 2

Alternative oral formulations:

• Ferric maltol is an option for patients intolerant to traditional iron salts, with comparable side effects to placebo and normalization of hemoglobin in 89% of cases after one year, though it is considerably more expensive 1
• Do not use modified-release iron preparations, as they are less suitable for prescribing 1, 2

When to Switch to Intravenous Iron

Indications for parenteral iron include:

• Intolerance to oral iron despite dose reduction to alternate-day regimen 2
• No hemoglobin increase after 2 weeks of adherent oral therapy 1, 2
• Conditions impairing absorption (post-bariatric surgery, active inflammatory bowel disease) 2
• Iron losses exceeding oral absorption capacity (ongoing heavy bleeding) 2
• Severe symptomatic anemia requiring rapid correction 1, 2
• Chronic disease, continuing blood loss, or gastrointestinal inflammatory pathology where parenteral iron is more effective 1

Critical Pitfalls to Avoid

Common errors that reduce efficacy or increase side effects:

• Do not prescribe twice- or three-times-daily dosing as first-line; it increases side effects without improving absorption due to hepcidin-mediated blockade 2, 3
• Do not switch to different traditional iron salts (ferrous fumarate, ferrous gluconate) for intolerance, as this is not supported by evidence; use alternate-day dosing or ferric maltol instead 1
• Do not continue ineffective oral therapy indefinitely; reassess at 2 weeks and escalate to IV iron if no response 1, 2
• Do not stop therapy when hemoglobin normalizes; continue for an additional 3 months to restore iron stores 1, 2

Special Considerations

Ferrous sulfate is superior to iron polysaccharide complex:

• In a randomized trial of children with iron-deficiency anemia, low-dose ferrous sulfate (3 mg/kg once daily) resulted in a greater increase in hemoglobin (mean difference 1.0 g/dL, 95% CI 0.4–1.6) and higher rates of complete IDA resolution (29% vs. 6%) compared to iron polysaccharide complex 4
• Ferrous sulfate also produced greater increases in serum ferritin (difference 10.2 ng/mL) and greater decreases in total iron-binding capacity 4

Efficacy is well-established:

• In young children with mild-to-moderate IDA, ferrous sulfate 2 mg/kg/day normalized hemoglobin in 95% and ferritin in 84% of patients at 3 months 5
• In adult women with IDA, ferrous sulfate treatment for 12 weeks produces significant improvements in all hematological and biochemical parameters 6